Rani Therapeutics Holdings Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Rani Therapeutics Holdings, Inc. (RANI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents3.765.8627.01117.4573.06
Short-Term Investments23.8842.6871.480.000.00
Cash & Short-Term Investments27.6448.5498.48117.4573.06
Accounts Receivable0.430.200.000.001.72
Inventory0.000.000.000.000.00
Other Current Assets1.682.311.942.140.17
Total Current Assets29.7450.85100.92119.6074.95
Non-Current Assets
Property, Plant & Equipment (Net)6.646.827.104.614.47
Other Non-Current Assets0.250.250.000.000.00
Total Non-Current Assets6.897.077.104.610.00
Total Assets36.6357.92108.03124.2179.42
Current Liabilities
Accounts Payable1.360.651.461.080.54
Short-Term Debt16.464.900.000.001.36
Current Portion of Long-Term Debt15.004.900.000.001.36
Accrued Liabilities1.791.471.761.040.55
Deferred Revenue0.000.000.000.002.72
Other Current Liabilities2.070.250.590.400.15
Total Current Liabilities19.897.994.822.645.31
Non-Current Liabilities
Long-Term Debt13.2524.4829.150.002.41
Other Non-Current Liabilities0.000.000.000.000.00
Total Non-Current Liabilities13.2524.4829.210.000.00
Total Liabilities33.1432.4734.022.647.72
Stockholders' Equity
Common Stock0.010.010.010.010.66
Retained Earnings-102.91-72.89-38.92-8.33-114.00
Accumulated Other Comprehensive Income0.01-0.01-0.070.000.00
Additional Paid-in Capital104.8985.7675.8455.740.00
Minority Interest1.5012.5837.1574.160.00
Shares Outstanding33.4326.0425.3019.710.00
Total Stockholders' Equity1.9912.8774.0047.4171.70
Total Liabilities & Equity36.6357.92108.03124.210.00